News

The generic version is named lamivudine and is manufactured by Aurobindo Pharma of India. According to the FDA, the copycat product will now be available for consideration for

Under the terms of the company’s license agreement with Bayer AG, the company is obligated to make a $1 million milestone payment to Bayer as a result of

BRAF is a protein that plays a central role in the growth and survival of cancer cells and is mutated in the majority of patients with melanoma and

In this study, conducted by researchers at Johns Hopkins University and Dartmouth Medical School, rats were treated with RTA403 and exposed to a potent natural carcinogen known as

MLN8054, an orally administered small molecule, was discovered and is being developed by Millennium scientists. This first clinical study will assess safety, determine the maximum tolerated dose, and

In his previous judgment, Justice Pumfrey ruled that Ranbaxy would not be able to distribute its generic version of the world’s best-selling drug in the UK, as the

The jury said that the drug was not responsible for the heart attack suffered by the plaintiff, a postal worker from Idaho, US, who suffered the heart attack

Emisphere intends to initiate patient enrollment before the end of November for a 90-day, multi-center, double-blind, randomized clinical trial. The four-arm study will evaluate the safety and efficacy

Under the terms of the agreement, Par will promote Cesamet to physicians in the US, whilst Valeant will record sales of the drug and fund all marketing expenses